• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Biomarin Pharmaceutical

Biomarin Pharmaceutical

  1. All
  2. Morningstar Articles
  3. 3rd Party
  4. Investing
  1. UPDATE: 10 Nasdaq stocks analysts expect to rise up to 50%

    UPDATE: 10 Nasdaq stocks analysts expect to rise up to 50%

  2. UPDATE: 10 Nasdaq stocks analysts expect to rise up to 50%

    UPDATE: 10 Nasdaq stocks analysts expect to rise up to 50%

  3. UPDATE: 10 Nasdaq stocks analysts expect to rise up to 50%

    UPDATE: 10 Nasdaq stocks analysts expect to rise up to 50%

  4. Here's a closer look at FDA commissioner nominee Scott Gottlieb's significant corporate ties

    Here's a closer look at FDA commissioner nominee Scott Gottlieb's significant corporate ties

  5. UPDATE: Here's a closer look at FDA commissioner nominee Scott Gottlieb's significant corporate ties

    UPDATE: Here's a closer look at FDA commissioner nominee Scott Gottlieb's significant corporate ties

  6. UPDATE: 10 Nasdaq stocks analysts expect to rise up to 50%

    UPDATE: 10 Nasdaq stocks analysts expect to rise up to 50%

  7. 10 Nasdaq stocks analysts expect to rise up to 50%

    10 Nasdaq stocks analysts expect to rise up to 50%

  8. UPDATE: 10 Nasdaq stocks analysts expect to rise up to 50%

    UPDATE: 10 Nasdaq stocks analysts expect to rise up to 50%

  9. UPDATE: 10 Nasdaq stocks analysts expect to rise up to 50%

    UPDATE: 10 Nasdaq stocks analysts expect to rise up to 50%

  10. Investing in Hidden Assets

    Use this screen to find high-growth businesses that have big ideas to keep competitors at bay.

12

©2017 Morningstar Advisor. All right reserved.